BROWN BROTHERS HARRIMAN & CO
Institutional investor · Portfolio as of Q1 2019
Top Holdings1,005 positions
ORACLE CORP | 17.2M | $921.9M | 6.4% | $48.13 | 0.00% | 1 qtr | First report 0 |
FLEETCOR TECHNOLOGIES INC | 3.4M | $846.8M | 5.8% | — | — | 1 qtr | First report 0 |
ALPHABET INC | 689,567 | $809.1M | 5.6% | $58.12 | 0.00% | 1 qtr | First report 0 |
COMCAST CORP NEW | 19.1M | $762.3M | 5.3% | $29.81 | 0.00% | 1 qtr | First report 0 |
BERKSHIRE HATHAWAY INC DEL | 3.6M | $725.5M | 5.0% | $200.89 | 0.00% | 1 qtr | First report 0 |
US BANCORP | 13.9M | $671.3M | 4.6% | $35.40 | 0.00% | 1 qtr | First report 0 |
NOVARTIS AG | 6.1M | $590.9M | 4.1% | $66.28 | 0.00% | 1 qtr | First report 0 |
ZOETIS INC | 4.8M | $478.8M | 3.3% | $93.81 | 0.00% | 1 qtr | First report 0 |
COPART INC | 7.6M | $459M | 3.2% | $15.15 | 0.00% | 1 qtr | First report 0 |
DIAGEO PLC | 2.7M | $446.5M | 3.1% | $135.92 | 0.00% | 1 qtr | First report 0 |
WELLS FARGO & CO | 8.9M | $430.3M | 3.0% | $39.51 | 0.00% | 1 qtr | First report 0 |
| 2.4M | $414.6M | 2.9% | $159.24 | 0.00% | 1 qtr | First report 0 | |
SABRE CORP | 16.1M | $344.3M | 2.4% | $20.43 | 0.00% | 1 qtr | First report 0 |
PAYPAL HLDGS INC | 3.1M | $326.8M | 2.3% | $102.69 | 0.00% | 1 qtr | First report 0 |
SCHEIN HENRY INC | 5.2M | $312.3M | 2.2% | $60.11 | 0.00% | 1 qtr | First report 0 |
CELANESE CORP DEL | 3.1M | $306.3M | 2.1% | $86.52 | 0.00% | 1 qtr | First report 0 |
BERKSHIRE HATHAWAY INC DEL | 963 | $290.1M | 2.0% | $301,215.00 | 0.00% | 1 qtr | First report 0 |
DOLLAR GEN CORP | 2.3M | $276.9M | 1.9% | $106.94 | 0.00% | 1 qtr | First report 0 |
BROWN FORMAN CORP | 4.9M | $257.7M | 1.8% | $45.81 | 0.00% | 1 qtr | First report 0 |
ALLEGION PLC | 2.7M | $244.2M | 1.7% | $83.34 | 0.00% | 1 qtr | First report 0 |
BROWN BROTHERS HARRIMAN & CO manages $14.5B across 1005 positions as of Q1 2019. Top holdings: ORCL (6.4%), FLT (5.8%), GOOG (5.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
First quarter we have for this fund: 1005 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $14.5B across 1005 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR